Do analysts prefer BIAF or BNBX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor BIAF or BNBX?

In the previous week, bioAffinity Technologies had 7 more articles in the media than Applied Dna Sciences. MarketBeat recorded 8 mentions for bioAffinity Technologies and 1 mentions for Applied Dna Sciences. Applied Dna Sciences' average media sentiment score of 0.36 beat bioAffinity Technologies' score of -0.32 indicating that Applied Dna Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment bioAffinity Technologies 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Applied Dna Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend BNBX or PPCB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Propanc Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend BNBX or ONCO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Onconetix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer BNBX or ONCO?

In the previous week, Onconetix had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 2 mentions for Onconetix and 1 mentions for Applied Dna Sciences. Applied Dna Sciences' average media sentiment score of 0.36 beat Onconetix's score of 0.00 indicating that Applied Dna Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Applied Dna Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Onconetix 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend GOVX or BNBX?

GeoVax Labs presently has a consensus target price of $150.00, indicating a potential upside of 30,949.47%. Given GeoVax Labs' stronger consensus rating and higher possible upside, research analysts clearly believe GeoVax Labs is more favorable than Applied Dna Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeoVax Labs 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate SLXN or BNBX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silexion Therapeutics 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Applied Dna Sciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to SLXN or BNBX?

In the previous week, Silexion Therapeutics and Silexion Therapeutics both had 1 articles in the media. Applied Dna Sciences' average media sentiment score of 0.36 beat Silexion Therapeutics' score of -0.64 indicating that Applied Dna Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Silexion Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Applied Dna Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Applied Dna Sciences (BNBX) Competitors

$0.14 0.00 (0.00%)

As of 09/4/2026 01:02 PM Eastern

Compare

BNBX vs. BIAF, PPCB, ONCO, GOVX, and SLXN

Should you buy Applied Dna Sciences stock or one of its competitors? Applied Dna Sciences's main competitors and comparable companies include bioAffinity Technologies (BIAF), Propanc Biopharma (PPCB), Onconetix (ONCO), GeoVax Labs (GOVX), and Silexion Therapeutics (SLXN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Applied Dna Sciences compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAF) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings.

bioAffinity Technologies has a beta of -1.11, indicating that its stock price is 211% less volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

In the previous week, bioAffinity Technologies had 7 more articles in the media than Applied Dna Sciences. MarketBeat recorded 8 mentions for bioAffinity Technologies and 1 mentions for Applied Dna Sciences. Applied Dna Sciences' average media sentiment score of 0.36 beat bioAffinity Technologies' score of -0.32 indicating that Applied Dna Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
bioAffinity Technologies	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Applied Dna Sciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

bioAffinity Technologies has a net margin of -257.30% compared to Applied Dna Sciences' net margin of -1,647.25%. bioAffinity Technologies' return on equity of -220.52% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	-257.30%	-220.52%	-136.76%
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%

1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 22.2% of Applied Dna Sciences shares are owned by institutional investors. 2.7% of bioAffinity Technologies shares are owned by insiders. Comparatively, 6.1% of Applied Dna Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

bioAffinity Technologies has higher revenue and earnings than Applied Dna Sciences. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Applied Dna Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$6.16M	1.49	-$14.91M	-$109.45	N/A
Applied Dna Sciences	$2.09M	0.43	-$15.16M	-$3.33	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
bioAffinity Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

bioAffinity Technologies beats Applied Dna Sciences on 7 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to Propanc Biopharma?

Applied Dna Sciences (NASDAQ:BNBX) and Propanc Biopharma (NASDAQ:PPCB) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

Applied Dna Sciences has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, Propanc Biopharma has a beta of 3.52, suggesting that its share price is 252% more volatile than the broader market.

Applied Dna Sciences has higher revenue and earnings than Propanc Biopharma. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Propanc Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.43	-$15.16M	-$3.33	N/A
Propanc Biopharma	N/A	N/A	-$58.92M	-$24.25	N/A

22.2% of Applied Dna Sciences shares are owned by institutional investors. 6.1% of Applied Dna Sciences shares are owned by insiders. Comparatively, 28.7% of Propanc Biopharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Applied Dna Sciences had 1 more articles in the media than Propanc Biopharma. MarketBeat recorded 1 mentions for Applied Dna Sciences and 0 mentions for Propanc Biopharma. Applied Dna Sciences' average media sentiment score of 0.36 beat Propanc Biopharma's score of 0.00 indicating that Applied Dna Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Applied Dna Sciences	Neutral
Propanc Biopharma	Neutral

Propanc Biopharma has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Propanc Biopharma's return on equity of -151.28% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Propanc Biopharma	N/A	-151.28%	-109.53%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Propanc Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Applied Dna Sciences and Propanc Biopharma tied by winning 6 of the 12 factors compared between the two stocks.

How does Applied Dna Sciences compare to Onconetix?

Applied Dna Sciences (NASDAQ:BNBX) and Onconetix (NASDAQ:ONCO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Onconetix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Applied Dna Sciences has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market. Comparatively, Onconetix has a beta of 2.68, meaning that its share price is 168% more volatile than the broader market.

In the previous week, Onconetix had 1 more articles in the media than Applied Dna Sciences. MarketBeat recorded 2 mentions for Onconetix and 1 mentions for Applied Dna Sciences. Applied Dna Sciences' average media sentiment score of 0.36 beat Onconetix's score of 0.00 indicating that Applied Dna Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Applied Dna Sciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Onconetix	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Onconetix has a net margin of -1,575.89% compared to Applied Dna Sciences' net margin of -1,647.25%. Onconetix's return on equity of -91.95% beat Applied Dna Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%
Onconetix	-1,575.89%	-91.95%	-53.76%

Onconetix has lower revenue, but higher earnings than Applied Dna Sciences. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Onconetix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Applied Dna Sciences	$2.09M	0.43	-$15.16M	-$3.33	N/A
Onconetix	$810K	5.52	-$14.03M	$248.12	0.00

22.2% of Applied Dna Sciences shares are held by institutional investors. Comparatively, 23.9% of Onconetix shares are held by institutional investors. 6.1% of Applied Dna Sciences shares are held by insiders. Comparatively, 0.3% of Onconetix shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Onconetix beats Applied Dna Sciences on 10 of the 13 factors compared between the two stocks.

How does Applied Dna Sciences compare to GeoVax Labs?

GeoVax Labs (NASDAQ:GOVX) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations.

In the previous week, Applied Dna Sciences had 1 more articles in the media than GeoVax Labs. MarketBeat recorded 1 mentions for Applied Dna Sciences and 0 mentions for GeoVax Labs. Applied Dna Sciences' average media sentiment score of 0.36 beat GeoVax Labs' score of 0.00 indicating that Applied Dna Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
GeoVax Labs	Neutral
Applied Dna Sciences	Neutral

GeoVax Labs has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Applied Dna Sciences' return on equity of -349.95% beat GeoVax Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GeoVax Labs	N/A	-743.64%	-394.74%
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%

GeoVax Labs presently has a consensus target price of $150.00, indicating a potential upside of 30,949.47%. Given GeoVax Labs' stronger consensus rating and higher possible upside, research analysts clearly believe GeoVax Labs is more favorable than Applied Dna Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GeoVax Labs	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Applied Dna Sciences has lower revenue, but higher earnings than GeoVax Labs. Applied Dna Sciences is trading at a lower price-to-earnings ratio than GeoVax Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GeoVax Labs	$2.49M	1.43	-$21.47M	-$11.34	N/A
Applied Dna Sciences	$2.09M	0.43	-$15.16M	-$3.33	N/A

GeoVax Labs has a beta of 3.66, suggesting that its stock price is 266% more volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market.

6.1% of GeoVax Labs shares are held by institutional investors. Comparatively, 22.2% of Applied Dna Sciences shares are held by institutional investors. 0.7% of GeoVax Labs shares are held by insiders. Comparatively, 6.1% of Applied Dna Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Applied Dna Sciences beats GeoVax Labs on 8 of the 15 factors compared between the two stocks.

How does Applied Dna Sciences compare to Silexion Therapeutics?

Silexion Therapeutics (NASDAQ:SLXN) and Applied Dna Sciences (NASDAQ:BNBX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

In the previous week, Silexion Therapeutics and Silexion Therapeutics both had 1 articles in the media. Applied Dna Sciences' average media sentiment score of 0.36 beat Silexion Therapeutics' score of -0.64 indicating that Applied Dna Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Silexion Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Applied Dna Sciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

11.0% of Silexion Therapeutics shares are owned by institutional investors. Comparatively, 22.2% of Applied Dna Sciences shares are owned by institutional investors. 0.8% of Silexion Therapeutics shares are owned by insiders. Comparatively, 6.1% of Applied Dna Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Silexion Therapeutics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Applied Dna Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Silexion Therapeutics has a beta of -0.36, indicating that its stock price is 136% less volatile than the broader market. Comparatively, Applied Dna Sciences has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Silexion Therapeutics has higher earnings, but lower revenue than Applied Dna Sciences. Applied Dna Sciences is trading at a lower price-to-earnings ratio than Silexion Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Silexion Therapeutics	N/A	N/A	-$11.91M	-$42.47	N/A
Applied Dna Sciences	$2.09M	0.43	-$15.16M	-$3.33	N/A

Silexion Therapeutics has a net margin of 0.00% compared to Applied Dna Sciences' net margin of -1,647.25%. Applied Dna Sciences' return on equity of -349.95% beat Silexion Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Silexion Therapeutics	N/A	-563.11%	-201.73%
Applied Dna Sciences	-1,647.25%	-349.95%	-283.96%

Summary

Applied Dna Sciences beats Silexion Therapeutics on 7 of the 13 factors compared between the two stocks.

Get Applied Dna Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNBX vs. The Competition

Export

Metric	Applied Dna Sciences	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$896K	$4.01B	$7.25B	$12.91B
Dividend Yield	N/A	3.60%	2.54%	9.13%
P/E Ratio	-0.04	12.65	273.27	25.43
Price / Sales	0.43	1,344.31	624.55	95.06
Price / Cash	N/A	45.00	28.92	35.62
Price / Book	0.10	16.39	11.01	6.39
Net Income	-$15.16M	-$22.85M	$3.49B	$358.69M
7 Day Performance	-3.66%	1.43%	1.63%	0.22%
1 Month Performance	-6.71%	6.00%	4.42%	-0.10%
1 Year Performance	N/A	49.38%	24.21%	14.04%

Applied Dna Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNBX Applied Dna Sciences	0.0892 of 5 stars	$0.14 flat	N/A	N/A	$896K	$2.09M	N/A	70
BIAF bioAffinity Technologies	0.8502 of 5 stars	$5.09 -1.9%	N/A	-85.8%	$3.07M	$6.16M	N/A	10
PPCB Propanc Biopharma	0.3812 of 5 stars	$1.07 -5.3%	N/A	-98.1%	$2.57M	N/A	N/A	1	Gap Up
ONCO Onconetix	1.034 of 5 stars	$0.64 -0.3%	N/A	-99.3%	$2.54M	$810K	0.00	12	Gap Down
GOVX GeoVax Labs	1.5236 of 5 stars	$0.63 -1.8%	$150.00 +23,705.7%	-97.2%	$2.23M	$2.49M	N/A	10	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNBX) was last updated on 9/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Applied Dna Sciences (BNBX) Competitors

BNBX vs. BIAF, PPCB, ONCO, GOVX, and SLXN

How does Applied Dna Sciences compare to bioAffinity Technologies?

Summary

How does Applied Dna Sciences compare to Propanc Biopharma?

Summary

How does Applied Dna Sciences compare to Onconetix?

Summary

How does Applied Dna Sciences compare to GeoVax Labs?

Summary

How does Applied Dna Sciences compare to Silexion Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Applied Dna Sciences (BNBX) Competitors

BNBX vs. BIAF, PPCB, ONCO, GOVX, and SLXN

How does Applied Dna Sciences compare to bioAffinity Technologies?

Which has more volatility and risk, BIAF or BNBX?

Does the media favor BIAF or BNBX?

Is BIAF or BNBX more profitable?

Do institutionals and insiders hold more shares of BIAF or BNBX?

Which has higher earnings and valuation, BIAF or BNBX?

Do analysts prefer BIAF or BNBX?

Summary

How does Applied Dna Sciences compare to Propanc Biopharma?

Which has more volatility and risk, BNBX or PPCB?

Which has stronger earnings and valuation, BNBX or PPCB?

Do institutionals and insiders hold more shares of BNBX or PPCB?

Does the media favor BNBX or PPCB?

Is BNBX or PPCB more profitable?

Do analysts recommend BNBX or PPCB?

Summary

How does Applied Dna Sciences compare to Onconetix?

Do analysts recommend BNBX or ONCO?

Which has more risk & volatility, BNBX or ONCO?

Does the media prefer BNBX or ONCO?

Is BNBX or ONCO more profitable?

Which has preferable valuation and earnings, BNBX or ONCO?

Do insiders and institutionals believe in BNBX or ONCO?

Summary

How does Applied Dna Sciences compare to GeoVax Labs?

Does the media favor GOVX or BNBX?

Is GOVX or BNBX more profitable?

Do analysts recommend GOVX or BNBX?

Which has better valuation & earnings, GOVX or BNBX?

Which has more risk and volatility, GOVX or BNBX?

Do institutionals & insiders believe in GOVX or BNBX?

Summary

How does Applied Dna Sciences compare to Silexion Therapeutics?

Does the media refer more to SLXN or BNBX?

Do insiders & institutionals have more ownership in SLXN or BNBX?

Do analysts rate SLXN or BNBX?

Which has more volatility & risk, SLXN or BNBX?

Which has preferable valuation & earnings, SLXN or BNBX?

Is SLXN or BNBX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNBX vs. The Competition

Applied Dna Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools